Chemomab Therapeutics (CMMB) Enterprise Value Growth (1y) (2018 - 2025)
Chemomab Therapeutics (CMMB) Enterprise Value Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Chemomab Therapeutics | 124.14 Mn | 113.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -68.64% |
| Sep 30, 2025 | 48.11% |
| Jun 30, 2025 | 25.69% |
| Mar 31, 2025 | 33.47% |
| Dec 31, 2024 | 34.38% |
| Sep 30, 2024 | 9.63% |
| Jun 30, 2024 | 51.99% |
| Mar 31, 2024 | 51.46% |
| Dec 31, 2023 | 76.52% |
| Sep 30, 2023 | 53.93% |
| Jun 30, 2023 | 48.53% |
| Mar 31, 2023 | 43.03% |
| Dec 31, 2022 | -162.70% |
| Sep 30, 2022 | 27.58% |
| Jun 30, 2022 | 22.59% |
| Mar 31, 2022 | 1.37% |
| Dec 31, 2021 | -29.82% |
| Sep 30, 2021 | -849.59% |
| Jun 30, 2021 | -658.39% |
| Mar 31, 2021 | -311.77% |